V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20118537 | 20087329 | 1.77 | 54.3 | Palliative (P) | 2019-01-30 | 2019-01-30 | Irinotecan | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101870308 |
| 20118600 | 20087330 | 1.6 | 40 | Palliative (P) | 2015-05-28 | 2015-07-03 | Hydroxycarbamide | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101652537 |
| 20118616 | 20087331 | 1.71 | 56 | Curative (C) | 2016-05-10 | 2016-05-14 | FOXTROT TRIAL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100423410 |
| 20118677 | 20087332 | 1.75 | 90 | Palliative (P) | 2019-07-16 | 2019-07-24 | MIC | 02 | N | OXALIPLATIN | 100902322 |
| 20118686 | 20087333 | 1.74 | 76.2 | Palliative (P) | 2018-02-15 | 2018-02-15 | ESPAC-4 TRIAL | 01 | N | RALTITREXED | 100312280 |
| 20118788 | 20087334 | 1.6 | 41.9 | 03 | 2016-07-06 | 2016-07-06 | ESPAC-4 TRIAL | 02 | N | SCOPE2 TRIAL | 100730227 |
| 20118912 | 20087335 | 1.75 | 79 | Adjuvant (A) | null | 2021-03-08 | EOF | 02 | N | SCOPE2 TRIAL | 100646355 |
| 20118980 | 20087336 | 1.69 | 47.9 | Palliative (P) | 2019-05-16 | 2019-05-16 | ECarboX | null | N | PACLITAXEL | 100678225 |
| 20119084 | 20087337 | 1.79 | 65.3 | null | 2018-07-31 | 2018-07-31 | Carbo F | 02 | N | DOCETAXEL | 100909922 |
| 20119241 | 20087338 | 1.66 | 63.7 | Palliative (P) | 2017-10-19 | 2017-10-20 | CHOP R | 99 | Y | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101277860 |
| 20119269 | 20087340 | 0 | 103.1 | 03 | 2018-02-20 | 2018-02-20 | OXALIPLATIN | 02 | N | RITUXIMAB | 100672395 |
| 20119273 | 20087341 | 1.66 | 51.8 | Palliative (P) | 2020-01-09 | 2020-01-09 | null | 02 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100337948 |
| 20119285 | 20087342 | 1.66 | 65.5 | Palliative (P) | null | 2020-08-30 | PACLITAXEL | 01 | N | DOCETAXEL | 101639307 |
| 20119473 | 20087343 | 1.57 | 45.5 | Palliative (P) | 2019-03-03 | 2019-03-05 | Bortezomib + MELPHALAN | 02 | N | BRIGATINIB | 100260275 |
| 20119490 | 20087344 | 1.69 | 78 | 03 | 2019-03-26 | 2019-03-29 | EOF | 02 | N | DOCETAXEL | 101513446 |
| 20119523 | 20087345 | 1.8 | 97 | Palliative (P) | 2018-05-05 | 2018-05-05 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101614789 |
| 20119558 | 20087346 | 1.56 | 62.5 | 03 | 2018-07-09 | 2018-08-05 | MITOMYCIN | 02 | Y | PACLITAXEL | 100829071 |
| 20119692 | 20087347 | 1.76 | 96 | null | null | 2017-08-03 | null | 02 | N | CARBOPLATIN + VINORELBINE | 100998086 |
| 20119729 | 20087348 | 1.74 | null | Palliative (P) | 2017-07-17 | 2017-08-09 | Fluorouracil + Streptozocin | N | N | PACLITAXEL | 100438889 |
| 20119763 | 20087349 | 1.6 | 48.5 | null | null | 2017-07-14 | ESPAC-4 TRIAL | N | N | ACTICCA-1 TRIAL | 100577132 |
| 20119819 | 20087350 | 1.75 | 79 | Palliative (P) | 2018-05-02 | 2018-05-08 | Cape +Cetuximab +Oxalip (3 wk) Load | 02 | Y | FCARBOST | 100531834 |
| 20119905 | 20087351 | 1.61 | 75 | Adjuvant (A) | 2018-04-07 | 2018-04-14 | ACELARATE Trial | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101806113 |
| 20119929 | 20087353 | 1.53 | 58 | Adjuvant (A) | 2018-09-28 | 2018-09-30 | PLATO Trials | 02 | N | PLATO TRIAL | 101496590 |
| 20119981 | 20087354 | 1.81 | 73 | Palliative (P) | 2016-01-22 | 2016-01-29 | CAPECITABINE + OXALIPLATIN + RT | 02 | Y | ACELARATE TRIAL | 101649541 |
| 20120169 | 20087357 | 1.74 | 65.2 | 03 | null | 2022-04-29 | Hepatoblastoma SR Cisplatin | 02 | null | CISPLATIN + FLUOROURACIL + RT | 101505774 |
| 20120206 | 20087358 | 1.6 | 68 | null | 2015-11-27 | 2015-11-27 | Fluorouracil + Folinic + RT Bossett | N | N | CISPLATIN + PEMETREXED | 101529809 |
| 20120230 | 20087360 | 1.75 | 55.6 | 03 | 2018-07-09 | 2018-07-13 | Olaparib | 02 | null | CAPITAL TRIAL | 100700867 |
| 20120251 | 20087361 | 1.73 | 96 | 03 | null | 2020-10-07 | GEM-P | N | N | CISPLATIN + FU + TRASTUZUMAB | 101743275 |
| 20120436 | 20087362 | 1.71 | 95.55 | Curative (C) | 2018-09-05 | 2018-09-24 | Carboplatin + Vinorelbine Oral | 02 | N | CAPECITABINE + STREPTOZOCIN | 100945369 |
| 20120501 | 20087363 | 1.68 | 14 | 03 | 2019-05-26 | 2019-05-26 | null | 01 | N | EOF | 101597204 |
| 20120522 | 20087364 | 1.66 | 77.9 | 03 | 2019-07-20 | 2019-07-20 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | PACLITAXEL | 101181621 |
| 20120656 | 20087366 | 1.77 | 64.5 | 03 | 2016-12-12 | 2016-12-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | ABVD | 100657819 |
| 20120674 | 20087367 | 1.73 | 96 | Palliative (P) | 2018-03-16 | 2018-03-24 | IBRUTINIB | 02 | N | EVEROLIMUS | 100500928 |
| 20120884 | 20087368 | 1.76 | 46.5 | Adjuvant (A) | 2015-07-04 | 2015-07-20 | CAV | 01 | null | LIPOSOMAL DOXORUBICIN | 101356947 |
| 20120909 | 20087369 | 1.77 | 51 | 03 | 2018-11-30 | 2018-12-09 | Capecitabine + Carboplatin + RT | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100858915 |
| 20120956 | 20087371 | 1.73 | 108.5 | null | 2018-12-25 | 2019-01-12 | Bortezomib + CYCLOPHOSPHAMIDE + Dexamethasone | 02 | N | ACELARATE TRIAL | 100746950 |
| 20121035 | 20087373 | 1.75 | 86.3 | Palliative (P) | 2016-04-30 | 2016-05-22 | CARBOPLATIN + FLUOROURACIL | 02 | N | HYDROXYCARBAMIDE | 101056946 |
| 20121095 | 20087375 | 1.65 | 56 | 03 | 2020-01-01 | 2020-01-18 | Raltitrexed | 02 | N | RITUXIMAB | 100966975 |
| 20121101 | 20087376 | 1.78 | 85.5 | 03 | 2018-12-13 | 2018-12-21 | Carbo F | N | N | NEO-AEGIS TRIAL | 101185358 |
| 20121143 | 20087377 | 1.7 | 104 | Palliative (P) | 2018-11-03 | 2018-11-10 | ARISTOTLE TRIAL | 02 | N | EVEROLIMUS | 100678656 |
| 20121167 | 20087378 | null | 10.2 | Palliative (P) | null | 2016-12-12 | CVP R | null | N | RITUXIMAB | 100317889 |
| 20121255 | 20087379 | 1.84 | 59.55 | Adjuvant (A) | 2022-01-01 | 2022-01-29 | PLATO Trials | 02 | N | PLATO TRIAL | 101389274 |
| 20121298 | 20087380 | 0 | 0 | Palliative (P) | 2017-10-04 | 2017-10-04 | MIC | 01 | N | GEMCITABINE + PACLITAXEL | 101563034 |
| 20121353 | 20087381 | null | 67 | Palliative (P) | 2017-04-26 | 2017-05-15 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | FLUOROURACIL + STREPTOZOCIN | 100378787 |
| 20121424 | 20087382 | 1.68 | 99 | Palliative (P) | 2019-03-08 | 2019-03-18 | Carboplatin + Vinorelbine IV | N | N | OXALIPLATIN | 100191559 |
| 20121439 | 20087383 | 1.53 | 55.9 | Palliative (P) | 2019-01-03 | 2019-01-07 | Panitumumab | 99 | N | ARISTOTLE TRIAL | 101870995 |
| 20121525 | 20087384 | 1.63 | 58 | Palliative (P) | null | 2018-11-25 | CHOP R - 21 days | 01 | N | ARISTOTLE TRIAL | 100161448 |
| 20121587 | 20087385 | 1.7 | 67.5 | 03 | 2021-03-05 | 2021-03-13 | Rituximab | 02 | N | PACLITAXEL | 100581338 |
| 20121595 | 20087386 | 1.66 | 46 | null | 2018-05-07 | 2018-06-12 | ARISTOTLE TRIAL | N | Y | EVEROLIMUS | 100428743 |
| 20121641 | 20087387 | 1.62 | 91 | Neo-adjuvant (N) | 2018-11-13 | 2018-12-08 | EOF | N | Y | CARBOPLATIN + VINORELBINE | 101666017 |